Biotech RadarJobs updated

COMPANY

On Target Laboratories

HQ: West Lafayette, IN source · ontargetlabs.com ↗

Clinical Phase 3

Keywords: oncology Ovarian Cancer Lung Neoplasms Lung Cancer Cancer in the Lung OTL38

Location: West Lafayette, IN · source · Oct 14, 2026

Profile checked Oct 10, 2026

5Trials (company is sponsor)

Timeline

  1. Trial start Phase 4: CYTALUX Dose Extension Study source ↗
  2. Trial start Phase 3: ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting source ↗
  3. Trial start Phase 3: OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer source ↗
  4. Trial start Phase 2: OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules source ↗
  5. Trial start 2: Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 5

RecordTitlePhaseStatusStartPrimary completion
NCT07469202CYTALUX Dose Extension StudyPhase 4Not yet recruitingAug 15, 2026Feb 28, 2027 (estimated)
NCT02872701OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung NodulesPhase 2CompletedMay 4, 2017Oct 31, 2018 (actual)
NCT04241315ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor TargetingPhase 3CompletedMar 26, 2020Oct 7, 2021 (actual)
NCT02317705Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer2Completed2014-122015-11 (actual)
NCT03180307OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian CancerPhase 3CompletedJan 26, 2018Apr 16, 2020 (actual)
Feedback